Autolus Therapeutics plc - American Depositary Share (AUTL) Social Stream



Autolus Therapeutics plc - American Depositary Share (AUTL): $3.88

0.31 (-7.40%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add AUTL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#188 of 345

in industry

AUTOLUS THERAPEUTICS PLC (AUTL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering AUTOLUS THERAPEUTICS PLC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 6 $21 $7 $13.2 $4.28 208.41%
2021-12-20 5 $21 $7 $12.8 $4.28 199.07%
2022-03-31 6 $21 $7 $12.8 $4.28 199.07%
2022-05-06 6 $13 $7 $10.75 $4.28 151.17%
2022-05-16 5 $13 $7 $10.75 $4.28 151.17%
2022-08-05 5 $12 $7 $10.25 $4.28 139.49%
2022-08-18 6 $12 $7 $10.6 $4.28 147.66%
2022-11-04 6 $12 $7 $10.4 $4.28 142.99%
2022-12-09 6 $12 $7 $9.4 $4.28 119.63%
2023-01-04 5 $12 $6 $8.6 $4.28 100.93%
2023-03-08 7 $12 $6 $8.833 $4.28 106.38%
2023-05-05 6 $12 $6 $8.4 $4.28 96.26%
2023-08-04 7 $12 $5 $7.833 $4.28 83.01%
2023-08-17 7 $12 $5 $8.333 $4.28 94.7%
2023-11-02 6 $12 $6 $9 $4.28 110.28%
2023-11-29 7 $12 $6 $9.166 $4.28 114.16%

The Trend in the Analyst Price Target


Over the past 19 days, AUTL's average price target has gone down $0.

AUTL reports an average of 227.9% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-08 7 12 6 8.833 2.04 332.99%
2023-04-05 6 12 6 8.400 1.82 361.54%
2023-05-05 6 12 5 8.200 1.89 333.86%
2023-11-10 7 12 6 9.166 3.43 167.23%
2023-11-29 7 12 6 9.166 4.08 124.66%

AUTL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.14 6 1 0 0 0 7

The Trend in the Broker Recommendations


AUTL's average broker recommendation rating improved by 0.36 over the prior 15 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, AUTOLUS THERAPEUTICS PLC's average analyst price target is higher than 207.93% of them.
  • To contextualize these metrics, consider that out of all US stocks, AUTOLUS THERAPEUTICS PLC's upside potential (average analyst target price relative to current price) is higher than 1510.5% of them.
  • To contextualize these metrics, consider that out of all US stocks, AUTOLUS THERAPEUTICS PLC's variance in analysts' estimates is lower than -1333.21% of them.
  • In the context of stocks in the small market cap category, AUTOLUS THERAPEUTICS PLC's number of analysts covering the stock is greater than 1313.77% of them.

Stocks similar to AUTOLUS THERAPEUTICS PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AVRO, MGTX, and SRRK.

What is the outlook for AUTL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!